CIK 0001635077 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aclarion, Inc.
Sign in to watch- Ticker
- ACON
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324725
- Phone
- 833 275 2266
- Business address
- 8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, 80021
- Former names
- Nocimed, Inc.
Securities
- ACON Common Stock Nasdaq
- ACONW Warrant Nasdaq
- Open-market buys, last 90 days
- $15,990
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$15,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-17 | Williams Amanda M Director | Purchase | +5,857 | $2.73 | $16K | 25,857 |
| 2026-08-14 | Gould Gregory A CFO | Purchase | +10,000 | $2.45 | $25K | 60,000 |
| 2026-08-13 | Bond Ryan Director | Purchase | +21,122 | $2.37 | $50K | 76,122 |
| 2026-08-13 | Wesemann William Director | Purchase | +2,150 | $2.34 | $5K | 23,713 |
| 2026-08-13 | Neal David K Director | Purchase | +7,500 | $2.40 | $18K | 30,002 |
| 2026-08-13 | Ness Brent Chief Executive Officer | Purchase | +5,234 | $2.31 | $12K | 111,534 |
| 2026-05-12 | Breidbart Scott Director | Purchase | +5,664 | $3.18 | $18K | 5,664 |
| 2026-05-11 | Neal David K Director | Purchase | +2,500 | $3.10 | $8K | 2,502 |
| 2026-05-11 | Ness Brent Chief Executive Officer | Purchase | +6,289 | $3.18 | $20K | 6,300 |
| 2026-05-06 | Wesemann William Director | Purchase | +1,562 | $3.30 | $5K | 1,563 |
| 2025-11-26 | Ness Brent Chief Executive Officer | Purchase | +10 | $6.20 | $62 | 11 |
| 2023-02-16 | Thramann Jeffrey John Executive Chairman | Purchase | +1 | $1,000.00 | $1K | 1 |
| 2022-12-29 | Ness Brent Chief Executive Officer | Purchase | +8,500 | $0.51 | $4K | 11,789 |
| 2022-12-29 | Ness Brent Chief Executive Officer | Purchase | +7,711 | $0.58 | $4K | 19,500 |
| 2022-12-29 | Lorbiecki John Paul Chief Financial Officer | Purchase | +4,100 | $0.43 | $2K | 4,100 |
| 2022-12-29 | Lorbiecki John Paul Chief Financial Officer | Purchase | +18,304.44 | $0.45 | $8K | 22,404.41 |
| 2022-12-28 | Ness Brent Chief Executive Officer | Purchase | +2,289 | $0.42 | $961 | 3,289 |
| 2022-04-22 | Bond Ryan Chief Strategy Officer | Purchase | +20,000 | $2.80 | $56K | 20,000 |
| 2022-04-21 | Wesemann William Director | Purchase | +11,000 | $4.35 | $48K | 52,736 |
| 2022-04-21 | Ness Brent Chief Executive Officer | Purchase | +1,000 | $4.35 | $4K | 1,000 |
Page 1 of 2 · 21 trades